DelveInsight’s, “ Gene Therapy Competitive landscape, 2025 ,” report provides comprehensive insights about 180+ companies and 200+ drugs in Gene Therapy Competitive landscape. It covers the ...

Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., (“Company” or “Adolore”) announced that ...

The world’s largest video platform has told content moderators to favor “freedom of expression” over the risk of harm in deciding what to take down.

The patients had sustained immune reconstitution and CD18 neutrophil expression of at least 10% relative to the normal expression, along with durable vector integration in peripheral-blood ...